R A Kenny Selected Research

R A Kenny Research Topics

Disease

9	Syncope (Fainting) 02/2021 - 09/2000
7	Orthostatic Hypotension (Postural Hypotension) 01/2018 - 04/2000
7	Dementia (Dementias) 12/2016 - 04/2000
6	Alzheimer Disease (Alzheimer's Disease) 12/2016 - 04/2000
5	Vasovagal Syncope 12/2016 - 03/2001
4	COVID-19 09/2022 - 01/2020
4	Dizziness (Lightheadedness) 02/2021 - 01/2018
4	Hypertension (High Blood Pressure) 01/2021 - 09/2005
4	Cognitive Dysfunction 01/2020 - 04/2000
4	Stroke (Strokes) 09/2015 - 09/2000
4	Hypersensitivity (Allergy) 09/2006 - 01/2000
2	Vitamin D Deficiency 01/2021 - 01/2020
2	Frailty 11/2017 - 05/2015
2	Heart Arrest (Cardiac Arrest) 07/2001 - 10/2000
1	Thrombosis (Thrombus) 01/2021
1	Lung Injury 01/2021
1	Obesity 01/2021
1	Infections 01/2020
1	Inflammation (Inflammations) 01/2020
1	Heart Diseases (Heart Disease) 01/2018
1	Atrial Fibrillation 11/2017
1	Pain (Aches) 02/2016
1	Cardiac Arrhythmias (Arrythmia) 09/2015
1	Fatigue 02/2009
1	Multiple System Atrophy 06/2007
1	Autonomic Nervous System Diseases (Dysautonomia) 06/2007
1	Parkinsonian Disorders (Parkinsonism) 06/2007
1	Synucleinopathies 09/2006
1	Ganglion Cysts (Ganglion) 09/2006
1	Hypotension (Low Blood Pressure) 06/2006
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 04/2006
1	Hallucinations (Hallucination) 12/2005
1	Sleep Wake Disorders 12/2005
1	REM Sleep Behavior Disorder 12/2005
1	Parkinson Disease (Parkinson's Disease) 10/2004
1	Unconsciousness (Loss of Consciousness) 07/2001
1	Amyloid Plaque 01/2001
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2001
1	Epilepsy (Aura) 10/2000
1	Ventricular Tachycardia 09/2000
1	Myocardial Infarction 09/2000
1	Hypesthesia (Numbness) 09/2000

Drug/Important Bio-Agent (IBA)

9	hydroxide ionIBA 01/2021 - 04/2000
3	Antihypertensive Agents (Antihypertensives)IBA 11/2017 - 09/2015
2	Vitamin D FDA LinkGeneric 01/2021 - 01/2020
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	Angiotensin IIIBA 01/2021
1	CytokinesIBA 01/2021
1	Biological ProductsIBA 01/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2020
1	Antidepressive Agents (Antidepressants)IBA 01/2018
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 12/2016
1	chemotactic factor inactivatorIBA 05/2015
1	nilvadipine (Escor)IBA 10/2011
1	ElementsIBA 09/2006
1	alpha-SynucleinIBA 09/2006
1	Peptides (Polypeptides)IBA 04/2006
1	Antipsychotic Agents (Antipsychotics)IBA 12/2005
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 12/2005
1	Levodopa (L Dopa)FDA LinkGeneric 12/2005
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 12/2005
1	Apolipoprotein E4IBA 09/2005
1	Apolipoproteins E (ApoE)IBA 10/2004
1	Adrenergic Receptors (Adrenergic Receptor)IBA 08/2004
1	SodiumIBA 06/2004
1	Donepezil (Aricept)FDA LinkGeneric 01/2003
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 03/2001
1	Nitroglycerin (Dynamite)FDA LinkGeneric 03/2001
1	Amyloid beta-PeptidesIBA 01/2001
1	ApolipoproteinsIBA 01/2001
1	Anticonvulsants (Antiepileptic Drugs)IBA 10/2000

Therapy/Procedure

6	Massage (Zone Therapy) 09/2006 - 01/2000
3	Length of Stay 02/2021 - 01/2021
3	Therapeutics 12/2016 - 01/2001
2	Secondary Prevention 02/2009 - 10/2004
1	Patient Care 09/2022
1	Conservative Treatment 12/2016
1	Polypharmacy 02/2016
1	Lower Body Negative Pressure 06/2006
1	Controlled Hypotension 07/2004
1	Contraindications 09/2000